Dr. Rong Li's lab at George Washington University focuses on understanding how adipocytes, a type of fat cell, influence breast cancer and antitumor immunity. The research explores the roles of PD-L1 in the breast tumor microenvironment and seeks to reveal new mechanisms by which T cells respond to the tumor environment, especially in the context of obesity. By investigating these interactions, the lab aims to improve immunotherapy strategies for breast cancer, particularly for patients struggling with obesity-related health challenges.

David Baker's research lab focuses on the design and development of new protein therapeutics to tackle public health challenges, particularly in response to pandemics like COVID-19. By using advanced computational techniques, the lab aims to create small proteins that can effectively neutralize viruses and mitigate severe immune responses. This research not only targets the current health crisis but also prepares methods for rapid responses to future infectious diseases.

Dr. Wenge Zhu's research lab at George Washington University focuses on understanding and overcoming resistance to breast cancer therapies. The lab investigates how specific molecular pathways influence both CDK4/6 inhibitor and aromatase inhibitor resistance, aiming to develop novel therapeutic strategies for patients with advanced breast cancer. By studying the roles of specific proteins and gene mutations, Dr. Zhu's team seeks to improve treatment outcomes for affected patients.